Arkolith/Insider Trading/IMVT/Form 4

Girao Tiago

Chief Financial OfficerImmunovant, Inc. (IMVT) · full profile →Form 4 · filed Jun 26, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$385K
Net Open-Market Flow
-$385K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 26, 2026Option exercise(M)10K$15.90$159K258K
Jun 26, 2026Sell(S)10K$38.46$385K248K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 26, 2026Option exercise(M)10K—$0284K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001764013-26-000072) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML